510(k) Report

510(k) · Cleared

Cleared

Abbott Multi-Collect Specimen Collection Kit, Abbott Real Time CT/NG

K140354510(k) TraditionalCleared May 9, 201486-day reviewClass II21 CFR 866.3390

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Molecular, Inc. · LSL Dna-Reagents, Neisseria

Cleared on May 9, 2014 after an 86-day review. The FDA summary names its predicate without a number. 2 later devices descend from it.

Decided
May 9, 2014
Review
86 days
Class
Class II
Product code
LSL
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2022: 1 descendant cleared2023: 1 descendant cleared2010201520202025
  1. This deviceK140354 Abbott Multi-Collect Specimen Collection Kit, Abbott Real Time CT/NGAbbott Molecular, Inc. · 2014
  2. Descendant · cites it directly · 1 of its ownK202977 Alinity m STI AssayAbbott Molecular, Inc. · 2022
  3. Descendant · 2 generations on · 0 of its ownK222379 Alinity m STI AssayAbbott Molecular, Inc. · 2023 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K202977Alinity m STI AssayAbbott Molecular, Inc. · 2022 · cites it directly1descendant
  • K222379Alinity m STI AssayAbbott Molecular, Inc. · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K140354Abbott Multi-Collect Specimen Collection Kit, Abbott Real Time CT/NGAbbott Molecular, Inc.2014—
+1K202977Alinity m STI AssayAbbott Molecular, Inc.2022—
+2K222379Alinity m STI AssayAbbott Molecular, Inc.20231

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202310
FIG. 1 — Lineage of K140354, 2014–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LSL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LSL device

  1. #1 K231329 Aptima Neisseria gonorrhoeae Assayscore 6.7 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Abbott RealTime CT/NG (List No. 8L07)
Named without a submission number
—
*—Abbott multi-Collect Specimen Collection Kit (List No. 9K12)
Named without a submission number
—
*—Abbott multi-Collect Specimen Collection Kit Swab (5W260)
Named without a submission number
—

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K202977Alinity m STI AssayAbbott Molecular, Inc.20221

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K202977 (Abbott Molecular, Inc., 2022) has gone furthest, with 1 descendant of its own.

How does its category compare?

All LSL devices

LSL Dna-Reagents, Neisseria: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · LSL

1in 2024

2007: 22008: 12009: 32012: 22013: 22014: 32017: 12018: 32024: 1
2007high 3 (2009) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LSL

90in 2018

2009: 62 days median2014: 86 days median2018: 90 days median
2007high 90 (2018) · low 62 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LSL

1in 2017

2017: 1
2007high 1 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LSL

41in 2025

2009: 42010: 12011: 12013: 12014: 42015: 62016: 62017: 102018: 72019: 142020: 32021: 42022: 112023: 192024: 172025: 41
2007high 41 (2025) · low 0 (2007)2025

MAUDE reports naming product code LSL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200936204
20100—01
20110—01
20122—00
20132—01
201438604
20150—06
20160—06
20171—110
201839007
20190—014
20200—03
20210—04
20220—011
20230—019
20241—017
20250—041
20260—0—

What is it indicated for?

The Abbott Realtime CT/NG assay isan invitro polymerase chain reaction (PCR) assay for the direct, qualitative detection of the plasmid DNA of Chiamydia trachomatis and the genomic DNA of Neisseria gonorrtoeaa. The assay may be used to test the following specimens from symptomatic individuals: female endoorvicai swab, clinician-collected vaginal swab, and patient-dallected vaginal swab specimens; male urethral swab specimens; and female and male urine…

Read the full statement (146 words)

The Abbott Realtime CT/NG assay isan invitro polymerase chain reaction (PCR) assay for the direct, qualitative detection of the plasmid DNA of Chiamydia trachomatis and the genomic DNA of Neisseria gonorrtoeaa. The assay may be used to test the following specimens from symptomatic individuals: female endoorvicai swab, clinician-collected vaginal swab, and patient-dallected vaginal swab specimens; male urethral swab specimens; and female and male urine specimens.

The Abbott multi-Collect Specimen Collection Kit isintended for the collection and transportation of male and female swab and urine specimens for the detection of Chiamydia traohomatis and Neisserta gononrhoeae per instructions provided. Refer to the specimen collection procedure in the package insert for the specimen collection instructions for specific sample types.

Self-collected vaginal swab specimens are an option for screening women when a pelvic exam is not otherwise indicated. The Abbott multi-Collect Specimen Collection Kit is not intended for home use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K140354: Abbott Multi-Collect Specimen Collection Kit, Abbott Real Time CT/NG.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K140354

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026